PROGNOSTICATION OF THE RISK OF SEVERE COVID-19 IN CHILDREN

Authors

DOI:

https://doi.org/10.11603/24116-4944.2024.2.15089

Keywords:

COVID-19, vitamins, pro-inflammatory cytokines, mathematical model

Abstract

The aim of the study – to develop a prediction model that allows identifying children at high risk of developing severe COVID-19 and applying preventive measures in a timely manner.

Materials and Methods. A total of 112 children aged 1 month to 18 years with confirmed COVID-19 diagnoses were examined. The study was based on data on vitamins and cytokine levels in serum, determined using enzyme-linked immunosorbent assay (ELISA).

Results and Discussion. The model incorporated key predictors of severe COVID-19 progression: pro-inflammatory cytokines TNF-α and IL-6, as well as vitamins A, D, and B9. These parameters were significant for assessing the risk of severe disease in children, enabling effective risk stratification and adaptation of preventive measures.

Conclusions. The study confirmed the critical role of pro-inflammatory cytokines TNF-α and IL-6, along with the serum levels of vitamins A, D, and B9, in predicting the risk of severe COVID-19 in children. The developed mathematical model based on multiple logistic regression analysis provides high accuracy in identifying patients with an elevated risk of severe disease. This facilitates the timely implementation of preventive measures and individualized treatment, contributing to the reduction of severe COVID-19 cases in children and the optimization of medical resource utilization.

Author Biographies

H. A. Pavlyshyn, I. Horbachevsky Ternopil National Medical Universitу

Doctor of Medical Science, MD, PhD, Professor, Chief of Pediatric Department No2

O. V. Labivka, I. Horbachevsky Ternopil National Medical Universitу

PhD  fellow,  Pediatric  Department  No2

References

Miller, S., Aikawa, Y., Sugiyama, A., Nagai, Y., Hara, A., Oshima, T., Amaike, K., Kay, S. A., Itami, K., & Hirota, T. (2020). An Isoform-Selective Modulator of Cryptochrome 1 Regulates Circadian Rhythms in Mammals. Cell chemical biology, 27(9), 1192–1198.e5. DOI: 10.1016/j.chembiol.2020.05.008. DOI: https://doi.org/10.1016/j.chembiol.2020.05.008

Ludvigsson, J. F. (2020). Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta paediatrica, 109(6), 1088-1095. DOI: 10.1111/apa.15270. DOI: https://doi.org/10.1111/apa.15270

Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients, 12(4), 988. DOI: 10.3390/nu12040988. DOI: https://doi.org/10.3390/nu12040988

Zdrenghea, M. T., Makrinioti, H., Bagacean, C., Bush, A., Johnston, S. L., & Stanciu, L. A. (2017). Vitamin D modulation of innate immune responses to respiratory viral infections. Reviews in medical virology, 27(1), e1909. DOI: 10.1093/infdis/jix232. DOI: https://doi.org/10.1002/rmv.1909

Ilie, P. C., Stefanescu, S., & Smith, L. (2020). The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging clinical and experimental research, 32(7), 1195-1198. DOI: 10.1038/s41598-020-73571-7. DOI: https://doi.org/10.1007/s40520-020-01570-8

Martineau, A. R., Jolliffe, D. A., Greenberg, L. et al. (2017). Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. BMJ, 356. DOI: 10.1136/bmj.i6583. DOI: https://doi.org/10.1136/bmj.i6583

Stephensen, C. B. (2001). Vitamin A, infection, and immune function. Annual review of nutrition, 21(1), 167-192. DOI: 10.1146/annurev.nutr.21.1.167. DOI: https://doi.org/10.1146/annurev.nutr.21.1.167

Shakoor, H., Feehan, J., Al Dhaheri, A. S. et al. (2021). Immune-Boosting Role of Vitamins D, C, E, Zinc, Selenium and Omega-3 Fatty Acids: Could They Help Against COVID-19? Frontiers in Immunology, 12, 634964. DOI: 10.3389/fimmu.2021.634964. DOI: https://doi.org/10.1016/j.maturitas.2020.08.003

Ablamunits, V., Lepsy, C. (2022). Blocking TNF signaling may save lives in COVID-19 infection. Molecular Biology Reports, 49(3), 2303-2309. DOI: 10.1007/s11033-022-07187-7. DOI: https://doi.org/10.1007/s11033-022-07166-x

Ganda, I. J., Putri, T. K. E., Rauf, S., Laompo, A., Pelupessy, N. M., Lawang, S. A., ... & Massi, M. N. (2023). IL-6 serum level, ARDS, and AKI as risk factors for the COVID-19 infection’s mortality in children. Plos one, 18(10), e0293639. DOI: 10.1371/journal.pone.0293639.

Musiienko, V., Sverstiuk, A., Lepyavko, A., Danchak, S., & Lisnianska, N. (2022). Prediction factors for the risk of diffuse non-toxic goiter development in type 2 diabetic patients. Polski merkuriusz lekarski: Organ Polskiego Towarzystwa Lekarskiego, 50(296), 94–98. PMID: 35436270. DOI: 10.36740/PM2022.50.29694

Chukur, O., Pasyechko, N., Bob, A., & Sverstiuk, A. (2022). Prediction of climacteric syndrome development in perimenopausal women with hypothyroidism. Przeglad Menopauzalny, 21(4), 236–241. DOI: 10.5114/pm.2022.123522 DOI: https://doi.org/10.5114/pm.2022.123522

Vaid, A., Somani, S., Russak, A. J., De Freitas, J. K., Chaudhry, F. F., Paranjpe, I., ... & Glicksberg, B. S. (2020). Machine learning to predict mortality and critical events in a cohort of patients with COVID-19 in New York City: model development and validation. Journal of medical Internet research, 22(11), e24018. DOI: 10.1038/s41746-020-00354-4. DOI: https://doi.org/10.2196/24018

Rossi, J. F., Chiang, H. C., Lu, Z. Y., Levon, K., van Rhee, F., Kanhai, K., ... & Klein, B. (2021). Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model to Predict Optimal Dosing to Completely Block IL-6 Activity. Blood, 138, 4004. DOI: 10.1182/blood-2021-150433. DOI: https://doi.org/10.1182/blood-2021-150433

Chen, L. D., Hu, L., Song, Y., Huang, Y. P., Yang, S. J., Yang, J., & Zhang, X. B. (2022). Role of serum IL-6 and TNF-α in coronavirus disease 2019 (COVID-19) associated renal impairment. European Journal of Inflammation, 20, 1721727X221126117. DOI: 10.1177/1721727X221126117. DOI: https://doi.org/10.1177/1721727X221126117

Yupari-Azabache, I., Bardales-Aguirre, L., Rodriguez-Azabache, J., Barros-Sevillano, J. S., & Rodríguez-Diaz, A. (2021). COVID-19 mortality risk factors in hospitalized patients: A logistic regression model. Revista de la Facultad de Medicina Humana, 21(1), 19–27. DOI 10.25176/RFMH.v21i1.3264 DOI: https://doi.org/10.25176/RFMH.v21i1.3264

Abu Shanap, M., Sughayer, M., Alsmadi, O., Elzayat, I., Al-Nuirat, A., Tbakhi, A., & Sultan, I. (2022). Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection. Frontiers in Immunology, 13, 919762. DOI: 10.3389/fimmu.2022.919762. DOI: https://doi.org/10.3389/fimmu.2022.919762

Yang, Q., Li, J., Zhang, Z., Wu, X., Liao, T., Yu, S., ... & Sun, J. (2021). Clinical characteristics and a decision tree model to predict death outcome in severe COVID-19 patients. BMC infectious diseases, 21, 1-9. DOI: 10.1186/s12879-021-05810-z. DOI: https://doi.org/10.1186/s12879-021-06478-w

Kass, D. A., Duggal, P., & Cingolani, O. (2020). Obesity could shift severe COVID-19 disease to younger ages. The Lancet, 395(10236), 1544-1545. DOI: 10.1016/S0140-6736(20)31024-2. DOI: https://doi.org/10.1016/S0140-6736(20)31024-2

Tagarro, A., Epalza, C., Santos, M. et al. (2021). Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain. JAMA pediatrics, 175(3), 316-317. DOI: 10.1001/jamapediatrics.2020.1346. DOI: https://doi.org/10.1001/jamapediatrics.2020.1346

Ganda, I. J., Putri, T. K. E. R., Rauf, S., Laompo, A., Pelupessy, N. M., Lawang, S. A., & Massi, M. N. (2023). IL-6 serum level, ARDS, and AKI as risk factors for the COVID-19 infection’s mortality in children. PLOS ONE, 18(10), e0293639. DOI: 10.1371/journal.pone.0293639 DOI: https://doi.org/10.1371/journal.pone.0293639

Published

2025-01-22

How to Cite

Pavlyshyn, H. A., & Labivka, O. V. (2025). PROGNOSTICATION OF THE RISK OF SEVERE COVID-19 IN CHILDREN. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 88–94. https://doi.org/10.11603/24116-4944.2024.2.15089

Issue

Section

PEDIATRICS